Clinical Trial Update: Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, pharmacokinetics and preliminary efficacy of SCY-635 given for 15 days in patients with chronic hepatitis C; the study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SCY-635 (SCY-635)

Snippet

Sponsor: Scynexis, Inc. | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED